Risks and prevention of severe RS virus infection among children with immunodeficiency and Down's syndrome

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Volumn 20, Issue 8, 2014, Pages 455-459

  Mori, Masaaki ^a   Morio, Tomohiro ^a   Ito, Shuichi ^a   Morimoto, Akira ^a   Ota, Setsuo ^a   Mizuta, Koichi ^a   Iwata, Tsutomu ^a   Hara, Toshiro ^a   Saji, Tsutomu ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Additional indications; Down's syndrome; Immunodeficiency; Palivizumab; Respiratory syncytial virus

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PALIVIZUMAB;

CHILD; COMPLICATION; DOWN SYNDROME; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFANT; INFECTION CONTROL; NEWBORN; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTOR;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; INFECTION CONTROL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 84925884845     PISSN: None     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.05.001     Document Type: Review

References (0)